Paper16634809
The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein.
Oppermann M and 9 others. Clin Exp Immunol, 2006. Cited by 123 papers, by iCite.
Cite this record
ConductScience Library. The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein. Papers, record 16634809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16634809
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | |
| Binding Sites, Antibody | |
| Complement C3b | |
| Complement C3d | |
| Complement Factor H | |
| Complement Pathway, Alternative | |
| Endothelial Cells | |
| Epitopes | |
| Heparin | |
| Humans | |
| Ligands | |
| Models, Biological | |
| Mutation | |
| Protein Conformation | |
| Zymosan |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8244456 | Thrombin generates monocyte chemotactic activity from complement factor H. | Immunology | 1993 | https://conductscience.org/library/papers/8244456 | PubMed |
| 2 | 12697737 | Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. | J Clin Invest | 2003 | https://conductscience.org/library/papers/12697737 | PubMed |
| 3 | 2972274 | Two populations of complement factor H differ in their ability to bind to cell surfaces. | Biochem J | 1988 | https://conductscience.org/library/papers/2972274 | PubMed |
| 4 | 7541419 | Identification of complement regulatory domains in human factor H. | J Immunol | 1995 | https://conductscience.org/library/papers/7541419 | PubMed |
| 5 | 11297706 | Complement. Second of two parts. | N Engl J Med | 2001 | https://conductscience.org/library/papers/11297706 | PubMed |
| 6 | 12391176 | Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome. | J Immunol | 2002 | https://conductscience.org/library/papers/12391176 | PubMed |
| 7 | 8955190 | Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. | J Immunol | 1996 | https://conductscience.org/library/papers/8955190 | PubMed |
| 8 | 16192651 | Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. | Am J Pathol | 2005 | https://conductscience.org/library/papers/16192651 | PubMed |
| 9 | 11429311 | Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage? | Trends Immunol | 2001 | https://conductscience.org/library/papers/11429311 | PubMed |
| 10 | 12424708 | Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. | Am J Hum Genet | 2002 | https://conductscience.org/library/papers/12424708 | PubMed |
| 11 | 7557433 | The baculovirus expression vector pBSV-8His directs secretion of histidine-tagged proteins. | Gene | 1995 | https://conductscience.org/library/papers/7557433 | PubMed |
| 12 | 1689363 | Determination of the epitope specificities of monoclonal antibodies using unprocessed supernatants of hybridoma cultures. | J Immunol Methods | 1990 | https://conductscience.org/library/papers/1689363 | PubMed |
| 13 | 9512460 | The C-terminus of factor H: monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteins. | Biochem J | 1998 | https://conductscience.org/library/papers/9512460 | PubMed |
| 14 | 11851332 | Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site. | J Mol Biol | 2002 | https://conductscience.org/library/papers/11851332 | PubMed |
| 15 | 16014385 | Early growth response proteins EGR-4 and EGR-3 interact with immune inflammatory mediators NF-kappaB p50 and p65. | J Cell Sci | 2005 | https://conductscience.org/library/papers/16014385 | PubMed |
| 16 | 14702193 | Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology. | Histol Histopathol | 2004 | https://conductscience.org/library/papers/14702193 | PubMed |
| 17 | 16026839 | Complement and diseases: defective alternative pathway control results in kidney and eye diseases. | Mol Immunol | 2006 | https://conductscience.org/library/papers/16026839 | PubMed |
| 18 | 8855297 | Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8855297 | PubMed |
| 19 | 12960213 | Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. | J Med Genet | 2003 | https://conductscience.org/library/papers/12960213 | PubMed |
| 20 | 1401896 | Ultrastructures and interactions of complement factors H and I. | J Immunol | 1992 | https://conductscience.org/library/papers/1401896 | PubMed |
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38388518 | Gliosis-dependent expression of complement factor H truncated variants attenuates retinal neurodegeneration following ischemic injury. | J Neuroinflammation | 2024 | https://conductscience.org/library/papers/38388518 | PubMed |
| 37306457 | The Complement-Targeted Inhibitor Mini-FH Protects against Experimental Periodontitis via Both C3-Dependent and C3-Independent Mechanisms. | J Immunol | 2023 | https://conductscience.org/library/papers/37306457 | PubMed |
| 36398537 | Protein therapeutics and their lessons: Expect the unexpected when inhibiting the multi-protein cascade of the complement system. | Immunol Rev | 2023 | https://conductscience.org/library/papers/36398537 | PubMed |
| 35194132 | A synthetic protein as efficient multitarget regulator against complement over-activation. | Commun Biol | 2022 | https://conductscience.org/library/papers/35194132 | PubMed |
| 34943047 | mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/34943047 | PubMed |
| 33986750 | Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder. | Front Immunol | 2021 | https://conductscience.org/library/papers/33986750 | PubMed |
| 33334893 | A novel soluble complement receptor 1 fragment with enhanced therapeutic potential. | J Biol Chem | 2021 | https://conductscience.org/library/papers/33334893 | PubMed |
| 33178228 | Tuning the Functionality by Splicing: Factor H and Its Alternative Splice Variant FHL-1 Share a Gene but Not All Functions. | Front Immunol | 2020 | https://conductscience.org/library/papers/33178228 | PubMed |
| 32923173 | Complement inhibitor factor H expressed by breast cancer cells differentiates CD14+ human monocytes into immunosuppressive macrophages. | Oncoimmunology | 2020 | https://conductscience.org/library/papers/32923173 | PubMed |
| 32765490 | Interaction of the Factor H Family Proteins FHR-1 and FHR-5 With DNA and Dead Cells: Implications for the Regulation of Complement Activation and Opsonization. | Front Immunol | 2020 | https://conductscience.org/library/papers/32765490 | PubMed |
| 32361709 | Atypical Hemolytic Uremic Syndrome (p.Gly1110Ala) with Autoimmune Disease. | Am J Case Rep | 2020 | https://conductscience.org/library/papers/32361709 | PubMed |
| 31719147 | Combining SPR with atomic-force microscopy enables single-molecule insights into activation and suppression of the complement cascade. | J Biol Chem | 2019 | https://conductscience.org/library/papers/31719147 | PubMed |
| 31554875 | CFH exerts anti-oxidant effects on retinal pigment epithelial cells independently from protecting against membrane attack complex. | Sci Rep | 2019 | https://conductscience.org/library/papers/31554875 | PubMed |
| 31273197 | Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies. | Nat Commun | 2019 | https://conductscience.org/library/papers/31273197 | PubMed |
| 30945073 | Altered Peripheral Blood Leucocyte Phenotype and Responses in Healthy Individuals with Homozygous Deletion of FHR1 and FHR3 Genes. | J Clin Immunol | 2019 | https://conductscience.org/library/papers/30945073 | PubMed |
| 30687332 | Utilization of Staphylococcal Immune Evasion Protein Sbi as a Novel Vaccine Adjuvant. | Front Immunol | 2018 | https://conductscience.org/library/papers/30687332 | PubMed |
| 29982679 | Biophysical analysis of sialic acid recognition by the complement regulator Factor H. | Glycobiology | 2018 | https://conductscience.org/library/papers/29982679 | PubMed |
| 29686068 | Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (CFH) gene family. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/29686068 | PubMed |
| 29485195 | Characterization of genetic predisposition and autoantibody profile in atypical haemolytic-uraemic syndrome. | Immunology | 2018 | https://conductscience.org/library/papers/29485195 | PubMed |
| 29335241 | The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential. | J Am Soc Nephrol | 2018 | https://conductscience.org/library/papers/29335241 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BBS9 | 27241 | PubTator's text mining | https://conductscience.org/library/genes/27241 | NCBI Gene |
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 | NCBI Gene |
| CFH | 3075 | PubTator's text mining | https://conductscience.org/library/genes/3075 | NCBI Gene |
| ERVK-13 | 100861467 | PubTator's text mining | https://conductscience.org/library/genes/100861467 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16634809
GET https://conductscience.org/api/papers/v1/16634809/references?page=2